Theriva Biologics Inc (AMEX:TOVX) does about 1.88M shares in volume on a normal day but saw 1222071 shares change hands in the recent trading day. The company now has a market cap of 3.81M USD. Its current market price is $1.68, marking a decrease of -6.15% compared to the previous close of $1.79. The 52 week high reached by this stock is $17.11 whilst the lowest price level in 52 weeks is $1.24.
Theriva Biologics Inc (TOVX) has a 20-day trading average at $2.9515 and the current price is -90.18% off the 52-week high compared with 35.48% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.0066 and its 200-day simple moving average is $8.3921. If we look at the stock’s price movements over the week, volatility stands at 14.71%, which increases to 19.66% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 34.76 to suggest the stock is neutral.
The consensus objective for the share price is $100.00, suggesting that the stock has a potential upside of 98.32% over the period.
The current price level is -45.56%, -59.12%, and -80.14% away from its SMA20, SMA50, and SMA200 respectively, with the TOVX price moving above the 50-day SMA on current market day. Theriva Biologics Inc (TOVX) stock is up 12.75% over the week and -47.83% over the past month. Its price is -84.38% year-to-date and -87.05% over the past year.
The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -8.5 above consensus estimates by 0.5. The company’s next earnings report forecasts estimating quarterly EPS at 0 and -26.5 for whole year.
To reach the target analysts have set, the stock logically needs to grow 98.32 percent from here.
The company has a return on investment of -77.05% and return on equity of -59.07%. The beta has a value of 1.30. Price to book ratio is 0.06.
